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DNA damage and DNA repair may mediate several cellular processes, like replication and transcription, mutagenesis and apoptosis and thus may be important factors for the organism development and pathology, including cancer.
DNA is constantly damaged by reactive oxygen species (ROS) and reactive nitrogen species (RNS) directly and also by products of lipid peroxidation (LPO), which form exocyclic adducts to DNA bases. A wide variety of oxidatively-generated DNA lesions are present in living cells. 8-oxoguanine (8-oxoGua) is one of the best known DNA damage due to its mutagenic properties. Among LPO-derived DNA base modifications the most intensively studied are ethenoadenine and ethenocytosine, highly miscoding DNA lesions considered as markers of oxidative stress and promutagenic DNA damage. Although at present it is impossible to answer directly the question concerning involvement of oxidatively damaged DNA in cancer etiology, it is likely that oxidatively  modified DNA bases may serve as a source of mutations that initiate carcinogenesis and are involved in aging (i.e. they may be causal factors responsible for the processes). To counteract the deleterious effect of oxidatively damaged DNA, all organisms developed several DNA repair mechanisms. It was observed that the repair efficiency of oxidatively damaged DNA is frequently decreased in cancer patients.




Oxidative stress and free radicals 

Oxidative stress is defined as unbalance in the formation and decomposition of reactive oxygen species, in favor of ROS increase. Reactive oxygen species (ROS) are oxygen containing molecules which may be radical, for example, superoxide (O2-) and hydroxyl radical (OH) or non-radical, for example hydrogen peroxide (H2O2) and singlet oxygen (1O2).  Free radicals are defined as any chemical moiety capable of existing with a lone electron in an orbital i.e. an unpaired electron (denoted as ).  It is this facet which makes free radicals more reactive than non-radicals, since orbital pairing of electrons increases stability. Formation of reactive oxygen (ROS) and nitrogen (RNS) species is involved in many human pathologic conditions including certain types of human cancers, e.g., lung, breast and colon, as well as atherosclerosis, neurodegenerative diseases and aging [1, 2]. ROS are generated in organisms by , X and UV radiation, biotransformation of dietary chemicals, some diet components, e.g. transient metal ions, inflammatory reactions and during normal cellular metabolism. The resulting disturbance of the pro-oxidant/antioxidant balance leads to a condition of oxidative stress, with subsequent oxidation of cellular components, activation of cytoplasmic/nuclear signal transduction pathways, modulation of gene and protein expression and alteration of activities of DNA and RNA polymerases [3]. 
Normal cellular metabolism appears to be a primary source for endogenous ROS. The most reactive ROS are hydroxyl radicals. Their cellular formation may be mediated by transition metal ions [4]. Labile iron and copper pool mediate production of OH [1] in the metal-catalysed Haber-Weiss and Fenton reactions: 

2O2- + 2H+  H2O2 + O2			(1)
Me3+ + O2-  Me2+ + O2			(2)
Me2+ + H2O2  Me3+ + OH + OH-		(3, Fenton reaction)   

ROS attack all cellular components causing oxidation and fragmentation of nucleic acids, proteins and lipids. 

OXIDATIVELY-DERIVED DNA BASE MODIFICATIONS

The attack of hydroxyl radicals on DNA results in single or double strand breaks, generation of abasic sites, base and sugar lesions. Hydroxyl radicals cause ionization of DNA bases as well as of other cellular components. Free radical attack upon DNA generates a whole series of DNA damage, among them a large number of pyrimidine- and purine-derived lesions in DNA [5]. Some of these modified DNA bases have considerable potential to affect the integrity of the genome [6, 7]. The principal products in oxidatively damaged DNA include 8-oxo-7,8-dihydroadenine (8-oxoAde), 8-oxo-7,8-dihydroguanine (8-oxoGua); and its deoxynucleoside equivalent, 8-oxodG), 5,6-dihydroxy-5,6-dihydrothymine (thymine glycol, Tg) and ring-opened lesions: 4,6-diamino-5-formamidopyrimidine (FapyAde) and 2,6-diamino-4-hydroxy-5-formamidopyrimidine (FapyGua) [8, 9].  Examples of the most significant DNA lesions are presented in Figure 1. 
8-oxo-7,8-dihydroguanine is one of the most widely studied lesions. The presence of 8-oxoGua residues in DNA leads to GCTA transversions unless repaired prior to DNA replication [10]. Therefore, the presence of 8-oxoGua in cells may lead to point mutations. Elevated level of 8-oxoGua accompanies the development of several human diseases. High concentration of 8-oxoGua was found in DNA of blood leukocytes and in urine of lung and colon cancer patients. 8-oxoGua was also increased in leukocytes of patients developing atherosclerosis and AIDS [11]. 

Figure 1. Major base lesions induced in DNA by oxidative stress and lipid peroxidation.

Oxidized DNA bases may derive either from the direct attack of ROS on DNA or may be incorporated from nucleotide pool by DNA polymerases. Purines and pyrimidines are from 100 to 1000-fold more susceptible to modification as mononucleosides and nucleotides or when they are present in ssDNA or RNA, than when they are protected in ds helix structure. Nucleotide pool modification is an important source of nucleic acids damage. Both DNA and RNA polymerases, although can discriminate unchanged and damaged nucleotides, this discrimination is not complete and they incorporate damaged nucleotides into nucleic acids with a different frequency [12, 13]. 
Unsaturated fatty acids also play an important role, since lipid peroxidation (LPO) yields plethora of stable derivatives, which add to nucleic acids forming exocyclic DNA adducts of high miscoding potential, as well as DNA-DNA and DNA-protein cross-links [14].
The major lipid peroxidation products are malondialdehyde, crotonaldehyde, trans-4-hydroxy-2-nonenal (HNE) and many other products [15]. The most extensively studied are 1,N6-ethenoadenine (A) and 3,N4-ethenocytosine (C) (Fig. 1). Although the precise pathway of ethenoadducts formation in cell is unknown, it is assumed on the basis of in vitro experiments that they are result of DNA bases interactions with LPO products. DNA-ethenoadducts are lesions of high miscoding potential in mammalian cells [16, 17], inducing also recombination and chromosomal aberrations [18], which are regarded a good predictive biomarker of cancer risk [19]. Exocyclic DNA adducts were found to be increased in inflammatory bowel disease, Crohn disease, and pro-cancerous metal storage disease such as Wilson disease and primary hemochromatosis [14, 20]. Recently, increasing attention is attracted to bulky DNA adducts formed by the long-chain LPO products, such as HNE. Increased level of HNE accumulation was observed in brain tissue and in cerebrum of patients suffering from several neurodegenerative disorders like Alzheimer’s (AD), Parkinson’s, Pick’s, amyotrophic lateral sclerosis and Huntington diseases [21]. Large amounts of HNE-modified proteins were found in the brains (globus pallidus) of Cockayne Syndrome patients [22]. The level of HNE-dG adducts in human brains (post mortem) was evaluated as 400 - 600 adducts per 109 normal nucleotides in the hippocampus [23].
These data unambiguously point to the link between oxidative DNA damage and human pathologies.
In view of the importance of DNA damage in carcinogenesis, it is conceivable that any agent capable of reacting with DNA and chemically modifying it could be carcinogenic. It is very likely that reactive oxygen species belong to this group. Moreover, many observations indicate a direct correlation between 8-oxoGua formation and carcinogenesis in vivo [6, 24] and that oxygen-derived radicals are known to induce mutations at hotspot codons of the human TP53 and Ha-ras genes [25, 26]. Therefore, oxidative damage to DNA may be critical to the development of cancer.

EFFECTS OF OXIDATIVELY DAMAGED DNA UPON THE CELL

There is a significant number of DNA base modifications, whose effects upon replication and transcription have been described. Many oxidative base lesions are mutagenic, irrespective of whether they are formed in situ, or arise by mis-incorporation from the deoxynucleotide pool. Overall it seems that oxidatively-generated DNA lesions are best described as weakly mutagenic, for example, 8-oxodG has mutation frequencies of 2.5 - 4.8% in mammalian cells, although lesion formation, persistence and accumulation in vivo could give this value greater significance. At least two cellular processes may diminish 8-oxoGua mutagenic potency: (i) DNA repair and (ii) translesion synthesis by Y family DNA polymerases. 8-oxoGua constitutes a moderate block for replicative DNA polymerases, which tend to incorporate A opposite 8-oxoGua. Accurate and efficient replication through the 8-oxoGua is ensured by DNA polymerase  [27], which can substitute replicative DNA polymerases upon replication inhibition. Mutations are not the only effect of oxidative DNA damage. Literature data suggest that events at the DNA level other than mutation are potentially involved in pathogenesis. Oxidants may affect gene expression either through ROS generation, or through interfering with transcription factor binding. Oxidants are known to modulate gene expression through alteration in cellular redox status. Redox status can alter transcription factor structure and binding of transcription factors to cognate DNA sequences through changes in cysteine reduction state and modification of zinc-finger domains [28]. Eucaryotic promoters usually contain GC-rich regions, either flanking TATA-box or recognized by transcription factors [29]. 8-oxoGua formation within this region may effect promoter methylation since it was shown that transfer of methyl group by methyltransferases is inhibited when the target sequence contains 8-oxoGua [30]. Thus may also change mRNA synthesis level.  

ROLE OF OXIDATIVELY DAMAGED DNA IN CARCINOGENESIS

It is clear that one of the consequences of oxidized base lesions persisting in DNA is mutation. DNA mutation is a crucial step in carcinogenesis and elevated levels of oxidatively-generated DNA lesions have been noted in many tumors, strongly implicating such damage in the etiology of cancer.
Oxidative mechanisms have been demonstrated to posses a potential role in the initiation, promotion and malignant conversion (progression) stages of carcinogenesis. Given that cumulative cancer risk increases with the age, and is associated with an accumulation of DNA damage, so oxidatively damaged DNA has been investigated in cancer. Lesions such as 8‑oxodG are established biomarkers of oxidative stress and coupled with their potential mutagenicity in mammalian cells. This has lead to their proposed potential as intermediate markers of a disease endpoint, for example cancer. Supportive of this proposal are the findings that GCTA transversions, potentially derived from 8-oxodG, have been observed in vivo, in the RAS oncogene and the TP53 tumour suppressor gene in lung and liver cancer [31,  32]. 
Ethenoadducts in mammalian cells cause a broad spectrum of transversion and transitions. A induces AT->GC, AT->TA, AT->CG [33], and C generates CG->AT, CG->TA, CG->GC base substitutions [34]. Such mutations are reported to be found in tumors associated with exposure to ethenoadducts forming chemicals in genes linked with cancer development e.g. TP53, Ha-ras, Ki-ras [35, 36].
Numerous studies have attempted to establish a relationship between levels of oxidatively damaged DNA and cancer. Elevated levels of damage are purported to arise as a consequence of an environment in the tumor low in antioxidant enzymes and high in ROS generation [37].

FACTORS THAT SHAPE THE BACKGROUND LEVEL OF 8-OXOGUA IN CELLULAR DNA AND THEIR RELEVANCE TO CARCINOGENESIS

Antioxidant vitamins, uric acid versus 8-oxoGua level in cellular DNA

Many epidemiological studies have reported an inverse association between vegetable and fruit consumption and occurrence of cancer and other degenerative diseases [38-40]. One of the possible mechanisms of this protective effect is by exerting the antioxidative activities of such plant food constituents as vitamins A, C and E. These antioxidant vitamins are effective free radical scavengers. They should protect biomolecules such as proteins, lipids and nucleic acids from oxidative damage. Another effective scavenger of ROS is uric acid [41]. Uric acid at physiological concentration is regarded as a main antioxidant and not only does it efficiently scavenge free radicals but it has also been shown to stabilize ascorbic acid in human serum [42] and reduce consumption of -tocopherol and -carotene [41].
One of the possible mechanisms of protective effect of antioxidant vitamins against cancer development may be by decreasing the amount of potentially mutagenic oxidatively- modified DNA bases. Duthie et al. [43] found that supplementation of healthy volunteers with vitamin C (100 mg/day), vitamin E (280 mg/day) and -carotene (25 mg/day) significantly reduced base damage in lymphocyte DNA. Collins at al. [44] demonstrated significant negative correlation between basal concentration of serum carotenoids and oxidatively modified pyrimidines. Supplementation of patients with carotenoids did not influence the level of oxidatively damaged DNA. The authors did not find any correlation between the damage and concentration of vitamins E and C. Moreover, the majority of intervention studies have failed to show clearly decreased oxidatively damaged DNA or cancer risk [45]. In our recently published study, a relationship between basal level of antioxidants (vitamins A, C and E and uric acids) and oxidatively damaged DNA represented by urinary excretion of 8-oxodG, 8-oxoGua as well as the level of oxidatively damaged DNA in leukocytes was assessed. Basal plasma levels of antioxidants may provide better estimation of antioxidant status than supplementation data, taking into account not only the consumption, which may reflect a transient state, but also the absorption and utilization. Our results revealed weak, statistically significant negative correlation between analysed antioxidants and all the measured parameters of oxidatively damaged DNA. Therefore, the results suggest that the level of oxidative DNA lesions shows limited but significant response to antioxidants analysed in this study and is more affected by many other cellular functions like antioxidant enzymes or DNA repair enzymes as well as genetics [46].
In another study we have found that the endogenous levels of the analyzed antioxidant vitamins in plasma of colon cancer patients were significantly lower than that in the control group [47]. Members of the studied groups were chosen randomly and in a way to match feeding habits and living conditions. Therefore, it is rather unlikely that the different concentration of vitamins in their blood was a result of lifestyle. Severe oxidative stress, characteristic for colon cancer, resulting in the production of ROS is responsible for consumption of the antioxidant vitamins. The decreased amount of uric acid in blood plasma of colon cancer patients also supports this assumption. This prooxidative environment resulted in increased amount of 8-oxodG in lymphocytes DNA of cancer patients, where the level of this lesion was significantly higher (p=0.0034) than in DNA of control group [48]. These findings suggest that oxidative stress may be characteristic not only for the diseased tissue but for some other tissues of the cancer patients.

Iron as possible cause of 8-oxoGua and ethenoadducts accumulation

Iron has the capacity to accept and donate electrons easily, changing between ferric (Fe2+) and ferrous (Fe3+) iron. Due to this feature it is useful component of cytochromes and oxygen binding molecules like hemoglobin and myoglobin. However, inside the cell iron can exist in another form, as a “free” or “labile” iron (LIP, iron not bound to proteins). LIP- associated iron is in dynamic equilibrium with other sequestered iron forms in the cell and is bound to cytosolic low molecular weight ligands that have not yet been identified. This iron form is catalytically active and participates in the reaction involved in the production of harmful ROS (the Fenton reaction) and lipid peroxidation [49]. Iron ions circulate bound to plasma transferring, whereas ferritin serves to accumulate it. We analyzed the broad spectrum of the components that affect iron metabolism and their possible association with the endogenous level of 8-oxodG [50,51]. No correlation has been found between plasma concentration of ferritin or transferrin saturation and the amount of 8-oxodG in the DNA of lymphocytes. On the other hand, a positive correlation has been determined between LIP and 8-oxodG [51]. This suggests that under physiological conditions LIP is available for catalysing the Fenton type reaction in a close proximity to cellular DNA. Neither the exact chemical nature of the complex between iron and DNA is known, nor it is established how iron can get into the nucleus.
There are experimental data which demonstrate the existence of free iron pool in patients with hemochromatosis [52]. Epidemiological data also show that elevation of the body iron level may increase the risk of liver cancer [53]. Iron overload may favor the persistence of harmful LIP, which can catalyse generation of the potentially carcinogenic 8-oxodG, as well as ethenoadducts in cellular DNA [54].

ACCUMULATION OF 8-OXOGUA AND ETHENOADDUCTS IN CANCER PATIENTS

Analyses of 8oxoGua in human samples

It is generally accepted that the products of 8-oxoGua repair in cellular DNA are excreted into the urine without further metabolism [55, 56]. There is a common belief that the presence of the modified nucleoside (8-oxodG) in urine represents either the primary repair product of the oxidative DNA damage in vivo, presumably nucleotide excision repair (NER) [57-59] or is the effect of nucleotide pool sanitation by MTH (Mut T Homolog) directed pathway (see also Nucleotide pool sanitation chapter).
However, oxidatively damaged DNA bases probably appear in urine as a consequence of the base excision repair (BER) activity [60, 61].
In our studies we have found that urinary excretion of 8-oxoGua and 8‑oxodG does not depend on diet in the case of humans and may reflect involvement of different repair mechanisms (respectively BER and NER) [62].
Since the level of the modified nucleosides/bases in urine may be a general marker of oxidative stress, we investigated whether the amount of 8‑oxoGua and its nucleoside form (8‑oxodG) excreted into urine was higher in cancer patients than in the control group. It was found that the amount of the modified base, but not the nucleoside, excreted into urine was approximately 50% higher in cancer patients suffering from lung, breast or prostate cancer than in the control group [63].
The higher level of 8-oxoGua in urine of cancer patients may be explained by the reported oxidative stress in cancer tissue [37, 63-65]. However, the amount of the modified base/nucleoside excreted into urine should represent the average rate of DNA damage in the whole body [56, 59]. It is doubtful that the elevated level of the base product in cancerous cells alone could account for the observed 50% increase of 8-oxoGua in urine. Our results suggest rather that oxidative stress, represented by the increased amount of the compound in urine, may be characteristic not only for the diseased tissue but also for some other tissues (or whole organism) of cancer patients. Although the precise mechanism(s) of the oxidative stress is still unknown, it has been recently documented that cancer patients showed signs of extensive granulocyte activation with a release of reactive oxygen species followed by a dramatic increase of 8-isoprostane, one of the biomarkers of oxidative stress [66]. It has been also shown that malignant cells can produce hydrogen peroxide at levels as large as those characteristic for stimulated polymorfonuclear leukocytes [67]. Therefore, one of the reasons for the observed oxidative stress in advanced stages of cancer may be a release of the large number of cancer cells into the blood stream [68] and their penetration into other tissues. Another reason for the observed phenomenon could be that some tumors may stimulate the defense systems of the body so that they react against the tumor to produce cytokines [69] . Some of the cytokines can be responsible for ROS production [70, 71]. 




It has been demonstrated that elevated levels of typical free radical-induced DNA base modifications, exist in human cancerous tissues when compared with the cancer-free surrounding tissue [63, 64, 72, 73]. It was shown that quantity of ethenoadducts in precancerous  tissues increases in comparison to not affected tissues. Polyps from FAP patients indicate about twofold higher incidence of A and C [74]. Significantly raised amounts of abovementioned lesions were reported in chronic pancreatitis, ulcerative colitis and Crohn’s desease, which all are inflammatory disorders that present elevated risk of cancer development [20].
It is not known whether these elevated levels of DNA lesions play a causative role in carcinogenesis or are merely the result of the disease. However, a treatment of laboratory animals with carcinogenic agents causes a similar pattern of oxidative base modification in their target organs before tumor formation occurs [75].
Our recent investigations of benign tumors showed that oxidative DNA damage might be a causative factor in cancer development. A higher endogenous level of 8-oxoGua in uterine myoma tissues was observed when compared to their respective tumor-free tissues [76]. One of the factors that may predispose malignant transformation is the greater size of the tumor [77]. We have found the positive correlation between the size of the tumor and the amount of 8‑oxoGua [76]. This suggests that the higher level of 8‑oxoGua and possibly other base lesions may be a risk factor that can determine the transformation of benign tumors to malignant tumors. Conversely, the increased levels of modified DNA bases may contribute to the genetic instability and metastatic potential of tumor cells in fully developed cancer.

REPAIR OF OXIDATIVELY DAMAGED DNA  

The major pathway to remove oxidized DNA bases and ethenoadducts is base excision repair. BER can be divided into five steps: (i) excision of damaged base by the specific DNA glycosylase and formation of apurinic/apyrimidinic (AP) site; (ii) cleavage of phosphodiester bond at AP site by AP-endonuclease or AP-lyase; (iii) removal of chemical groups interfering with gap filling and ligation; (iv) gap filling; (v) ligation [78]. The first step of the BER pathway, recognition and excision of damaged base by the specific DNA glycosylase, may be tremendously influenced by the second BER pathway enzyme, AP endonuclease. Major human enzyme APE1 in vitro stimulates excision of 8-oxoGua and C up to 400 fold by increasing enzymes’ turnover on damaged DNA [79, 80]. Other proteins that may affect excision rate of oxidative DNA damage are: XRCC1 (a platform protein, which is recruited to the site of damage by several DNA glycosylases and stays till ligation, regulating consecutive stages of the BER , PARP1 (polyADP ribose polymerase, which binds to free DNA ends and protects them against degradation, participates in chromatin relaxation and modulates binding of repair proteins to the site of damage by interaction with poly(ADP-ribose) chains [81-83]), PCNA (proliferating cells nuclear antigen, DNA polymerase processivity subunit in LP-BER), RFC (replication factor C, loading PCNA on DNA), WRN helicase (deficient in Werner syndrome, a premature aging disease [84]) or CSB (helicase/3’exonuclease, deficient in Cockayne syndrome, neurodevelopmental and premature aging disease [85]). 

System “GO” for 8-oxoGua excision from DNA.

Repair of 8-oxoGua is a multi-step process, which includes activity of three proteins MTH, OGG1 and MYH acting in so called “GO” system (Fig. 2.). MTH is pyrophospohydrolase, which eliminates 8-oxodGTP from cellular nucleotide pool and prevents its incorporation into DNA. When 8-oxoGua arises via DNA base oxidation, it is removed by BER glycosylase OGG1 that excises 8-oxoGua paired with C or T. If repair is not completed before replication, replicative DNA polymerases frequently incorporate dA opposite 8-oxoGua, which results in GC->TA substitutions. Mispairs 8-oxoGua:A may be repaired via elimination of dA by MYH glycosylase. Subsequently DNA polymerase  fills the gap in DNA strand with dCTP and generates 8-oxoGua:C pair that can be processed by OGG1, leading to restoration of initial G:C pair. If 8-oxoGua is incorporated into DNA from nucleotide pool, and paired with A, it can be excised by two proteins: OGG2 and NEIL2. However, mechanisms of distinguishing between template and new synthesized DNA strand by repair glycosylases haven’t been yet proposed.  






All cells from bacteria to humans are equipped with phosphohydrolases that hydrolyse triphosphates of damaged nucleotides to monophosphates. Nucleotide monophosphate kinases can discriminate between damaged and unchanged nucleotides, and damaged nucleotides are not re-circulated to cellular pool of nucleoside triphosphates, but instead they are dephosphorylated by nucleotidases and extruded from the cell, which prevents their incorporation into DNA by DNA polymerases [86]. 
	
A role of MTH1 protein (8-oxodGTPase)

	In E.coli the MutT protein, is a pyrophosphohydrolase (i.e., 8-oxodGTPase) that hydrolyzes 8-oxodGTP to 8-oxodGMP and inorganic pyrophosphate, thus eliminating this damaged dGTP from dNTP pool and preventing it from being incorporated into DNA [87]. Escherichia coli strain carrying a knockout mutation in the mutT gene coding for this enzyme demonstrates very strong mutator phenotype [88] characterized by at least 1000-fold increase in the frequency of AT → CG point mutations [89, 90]. Maki and Sekiguchi found that MutT protein most effectively hydrolyzes 8-oxodGTP thereby preventing its incorporation into DNA during DNA replication process [87]. Thus, an antimutagenic function of MutT protein has been attributed to decomposing 8-oxodGTP which otherwise may cause AT → CG transversions. Mammalian homologues of bacterial mutT gene were cloned, characterized, and designated MTH1 genes (mutT homologue 1) [91]. Transfection of the human MTH1 gene into mutT ˉ  E. coli resulted in partial reversal of mutator phenotype [92], and transfection of mouse and rat genes resulted in a complete reversal [93, 94] of the high AT → CG point mutation rate, typical for incorporational mutagenicity of 8-oxodGTP observed in these mutants. Therefore, it has been postulated that mammalian MTH1 proteins coded by these genes play the same role in sanitizing free nucleotide pools. Indeed, human [95], mouse [93, 96], rat [94, 97], and hamster [98, 99] MTH1 proteins are nucleoside 5′-triphosphate pyrophosphohyrolases that very effectively decompose 8-oxodGTP. This is why these mammalian enzymes are most frequently called 8‑oxodGTPases. Although hMTH1 decomposes most effectively 2-hydroxy-2′-deoxyadenosine 5′-triphosphate (2-OH-dATP) [100], 2-hydroxyadenosine 5′-triphosphate (2-OH-ATP) [101], 8‑oxodGTP [95], and 8-oxo-2′-deoxyadenosine 5′-triphosphate (8-oxodATP) [100], it is also capable of hydrolyzing less effectively 8-oxoguanosine 5′-triphosphate (8-oxoGTP) [102], 8-chloro-2′-deoxyguanosine 5′-triphosphate (8-Cl-dGTP) [103] and canonical deoxyribonucleoside and ribonucleoside 5-triphosphates, such as dGTP [95]. Four isolated forms of hMTH1 protein (p18, p21, p22 and p26) demonstrate equal activity towards 8‑oxodGTP [104]. Human 18-kDa 8-oxodGTPase was shown to be located mostly in cytosolic and mitochondrial soluble fractions [105], although rat tissues revealed also an apparent nuclear localization of MTH1 protein [106].	
	
	MTH1 and carcinogenesis  

Recent models of the cancer development process assume a formation of the mutator cell in the early stage of the cell transformation. A knockout of MTH1 gene was anticipated to generate a mammalian mutator cell. However, such a knockout mutation in MTH1 gene has not been discovered in mammalian cancer cells. Surprisingly, instead of that, a characteristic overexpression of MTH1 has been noticed in different cancer cells and tissues as compared to their healthy counterparts [107-111]. Since this overexpression in the cancer cells was most frequently assigned to a state of persistent oxidative stress in cancer cells, it has also been proposed that MTH1 overexpression might be a marker of the oxidative stress [107, 109]. Although an induction of MTH1 expression by high concentrations of hydrogen peroxide 111 and free radical-generating crocidolite asbestos [112] has been recently demonstrated, different aspects of MTH1 gene expression regulation in normal and cancer cells still remain unclear.
A better insight into the role of MTH1 protein has been acquired by the creation of MTH1 nullizygous cell lines and mice [113]. These transgenic mice, defective in MTH1 gene and devoid of 8-oxodGTP pyrophosphohydrolase activity, demonstrated higher incidence of lung, liver, and stomach cancers accompanied by 2-fold increase in spontaneous mutation frequency in Hprt gene, as compared to wild type mice [114]. Nevertheless, this slightly higher mutation rate has not been confirmed in a more recent study that showed the same level of mutation frequency in rpsL reporter gene of E. coli, introduced into both MTH1+/+ and MTH1ˉ /ˉ backgrounds [115].
In our recent study we have found that 8-oxoGua level in human DNA is determined not only by its excision rate, but also by the frequency of its incorporation from oxidatively modified  nucleotide pool into DNA by DNA polymerases, and the latter may be the most important contributor [116]. When studying 8-oxoGua level in DNA, OGG1 repair activity and MTH1 activity in tumors and surrounding lung tissue, without histological changes (normal lung) of lung cancer patients, we found that 8-oxoGua level was lower in tumor than in normal lung tissue, OGG1 activity was also lower in tumor, but MTH1 activity was higher in tumor than in normal lung. The activity of MTH1 was three orders of magnitude higher than that of OGG1. This tremendous difference can be attributed mostly to differences in the turnover of these enzymes, since the expression of MTH1 and OGG1 mRNAs is similar [117]. The role of MTH1 protein is further highlighted by observation that over expression of MTH1 protein in mismatch deficient cell lines decreased the mutation rates to normal and reduced microsatellites instability which was accompanied by reduction of the 8-oxo-dG level in DNA [118]. Also expression levels of MTH1 mRNA were inversely proportional to the levels of 8-oxodG in DNA in 11 human lung cancer cell lines and SV-transformed non-tumorigenic human bronchial epithelial cells [109]. The higher activity of 8-oxodGTPase also coincided with lower background levels of 8-oxodG in DNA of fetal compared with maternal mouse organs [96].





Epidemiological studies suggest that the etiology of some types of human cancers is closely related to chronic inflammations and infections. We were studying repair of oxidative DNA damage in lung cancer patients. Lung cancer is the most frequent cancer type all over the world [119, 120]. In Caucasian population approximately 80 % of lung cancer cases are caused by tobacco smoking [119, 120]. Tobacco smoke contains over 4,000 compounds, and generates the formation of ROS as well as chronic lung inflammation [121]. ROS and RNS can cause lipid peroxidation, oxidation of DNA and protein thiols, protein nitrosylation [15].
We have investigated repair of three oxidative DNA damages, 8-oxoGua and two lesions induced by interaction of lipid peroxidation products with DNA, 1,N6-ethenoadenine and 3,N4-ethenocytosine. These DNA lesions reveal high miscoding potential in mammalian cells [16, 17, 122] inducing also recombination and chromosomal aberrations [18]. 
In humans the major 8-oxoGua DNA glycosylase is OGG1 [123], while A is eliminated from DNA by alkylpurine-DNA-N-glycosylase (ANPG) [124] and C by mismatch specific thymine-DNA-glycosylase (TDG) [125]. Both latter enzymes are monofunctional DNA-glycosylases and require AP-endonuclease to incise DNA at the site of the removed base, while OGG1 is glycosylase/AP-lyase. OGG1 AP-lyase activity is, however 10-fold lower than that of N-glycosylase, so strand incision is mostly dependent on the availability of APE1 [79, 80].
TDG excises C from the whole genome [125]. CpG sites are additionally processed by MBD4 glycosylase, which removes C and T from G:T mismatches specifically from CpG sites [126]. It was also suggested that ethenoadducts may also be repaired via oxidative dealkylation catalyzed by AlkB type protein(s) [127]. AlkB contribution to overall repair yield of this type of DNA damage is not elucidated. 
We have measured the level, and repair rates of 8-oxoGua, A and C in blood leukocytes of lung cancer patients, as well as in blood leukocytes of healthy individuals, matched with cancer patients for age, gender and lifestyle habits. 
When comparing repair activities between cancer patients and controls, we have observed that repair capacity for 8-oxoGua and A was significantly lower in blood leukocytes of lung cancer patients than in leukocytes of healthy volunteers [128, 129]. Studies of Livneh and coworkers also demonstrate decreased 8-oxoGua repair capacity in lung as well as in head and neck cancer patients [130, 131]. Consistently, 8-oxoGua level in DNA from cancer patients’ leukocytes was higher than that in healthy controls. Urinary excretion of 8-oxoGua was higher in smoking individuals, regardless of their health status, than in non-smokers. Since oxidatively-generated DNA insult represented by urinary excretion of oxidatively-derived DNA lesions was similar in both groups of subjects with similar smoking status, it appears likely that a higher rate of oxidative damage generation in cellular DNA of lung cancer patients is a result of the deficiency of repair mechanism(s) in this group. 
Lung adenocarcinoma is a histological type of cancer which etiology is linked to prolonged inflammation and healing of scars [132]. Repair activities for C were lower than in healthy volunteers only in individuals with AD. Also the difference in A repair rate between healthy volunteers and cancer patients was much bigger for AD than for all cancer patients (Fig. 3) No differences were observed in repair rates of 8-oxoguanine. This suggests that the etiology of lung adenocarcinoma may be related to inefficient repair of exocyclic DNA adducts, deriving from lipid peroxidation (LPO). In only two other studies LPO has been linked to progression of lung cancer [133, 134]. However, this suggests that the development of histological types of lung cancer is realized by different pathways, and that in the development of lung adenocarcinoma the deficiency of repair of lipid peroxidation derived DNA damage is one of the risk factors.
These functional studies show that decreased efficiency of BER to eliminate from DNA oxidatively-generated DNA lesions, 8-oxoGua, A and C may be a risk factor for the development of lung, and other cancers. Molecular mechanisms responsible for this phenomenon are, however, only partially elucidated, and may include repair genes polymorphism, transcriptional activation/down-regulation of specific repair genes by inflammatory processes and certain nutrients, post-translational modifications of repair enzymes and possibly other factors. 


Figure 3. Base excision activity toward ethenoadducts: (A,C) A; (B,D) C in lung cancer patients. SQ - squamous cell carcinoma; AD – adenocarcinoma.

Polymorphism of Base Excision Repair genes 

Several polymorphisms of DNA glycosylases responsible for excision of 8-oxoGua are known, and their presence in human genomes was linked to the risk of developing specific types of cancers. It has been suggested that polymorphism in DNA repair genes may be associated with differences in the repair efficiency of DNA damage [135]. Some studies suggest involvement of hOGG1 polymorphism in several human cancers [136].
Few hOGG1 polymorphisms were described with the most common Ser326Cys. 326 Cys allele is found in approximately 40% of Caucasian population. 326Cys OGG1 binds DNA damage with significantly lower affinity and excises 8-oxoGua from duplex DNA and cleaves abasic sites at rates 2- to 6-fold lower than the wild-type enzyme, depending upon the base opposite the lesion. In contrast to wild type enzyme OGG1 326 Cys variant binds damaged DNA as a dimer, both in vitro and in human cells and is not significantly stimulated by the presence of AP-endonuclease [137], as well as is not relocalized to nucleus during S-phase of the cell cycle [138]. The altered substrate specificity, lack of stimulation by AP-endonuclease 1 (APE1) and anomalous DNA binding conformation of 326Cys OGG1 may be responsible to its linkage to cancer incidence [137]. Recent finding of Bravard and coworkers [139] shows that OGG1 Cys variant is more sensitive to inactivation by oxidizing agents than Ser variant, and reducing environment may restore excision activity of Cys variant to that of Ser one. This might suggest that under the oxidative stress individuals who carry OGG1 326 Cys/Cys genotype may be under increased risk of cancer development.
It was suggested that the presence of two hOGG1 326Cys alleles confers a 2-fold increased risk of lung cancer [140, 141], and also an elevated risk of prostate cancer and nasopharyngeal carcinoma [142, 143], but not of colon cancer [144]. However, the results of other studies are contradictory. 8-oxoGua excision rate probably depends on many other factors, since it was reported that excision activities in human lymphocytes were not affected by the polymorphic status at codon 326 of the hOGG1 gene [145]. Since excision activity of OGG1 glycosylase may depend on several protein interactions among partners of the BER pathway, e.g. XRCC1 and APE1, further studies are needed to examine whether the polymorphism of Ser326Cys of hOGG1 is a significant risk factor for human cancers associated with oxidative DNA damage.
Less frequent OGG1 polymorphisms are Arg46Gln and Arg154His [146]. Both variants were found in human lung and gastric cancers, respectively, and later in blood leukocytes. Both have a reduced activity for excision of 8-oxoGua. In addition, Arg 154 change to His relaxes the OGG1 requirement for a pyrimidine opposite 8-oxoGua. Since replicative DNA polymerases readily incorporate A opposite 8-oxoGua, such change in substrate specificity renders this OGG1 variant a mutator character. Due to the scarcity of both polymorphisms their relation with human cancers was not established. 
Bacterial MutY glycosylase and its human homolog hMYH excise adenine incorporated into DNA opposite 8-oxoGua by replicative DNA polymerases. In bacteria lack of MutY protein increases 1000-fold spontaneous mutation rate, pointing to the enzyme’s role in correcting replicative errors [147]. In humans alternative splicing gives type 1 (535 aminoacids) protein, which localizes in mitochondria and type 2 (521 aminoacids) lacking mitochondria transport signal and localizing in nucleus. Seven different polymorphisms of hMYH gene are known [146]. Polymorphisms Gln324His of type 1 protein and Gln310His of type 2 do not change the enzyme activity. Two other base substitutions Gly328Asp and Tyr165Cys diminish the glycosylase activity towards 8-oxoGua:A and are risk factors for colorectal tumors. These hMYH polymorphisms in colorectal tumors were associated with GC→TA transversions in APC gene [146]. Two stop mutations, Tyr90 to stop and Glu466 to stop are also associated with a possible risk of colorectal tumors. Two intronic polymorphisms were also found: G/C in intron 1, which induces alternative splicing and reduces translation efficiency and A/G in intron 10, inducing production of truncated protein, which is not localized in the nucleus. 
Surprisingly, very few polymorphisms were found in human genes coding for DNA glycosylases excising exocyclic DNA adducts A (ANPG) and C (TDG). Those, which were found are scarce and do not change the efficiency of excision [148, 149].
Several sequence variants were identified in APE1 gene, of which the major are Gln51His, Ile64Val and Asp148Glu. Asp148Glu was associated with hypersensitivity to ionizing radiation [150], and the presence of Ile64Val decreased lung cancer risk [151]. Association of Asp148Glu polymorphism with lung and other cancers was not demonstrated [152, 153].
More than 60 validated single nucleotide polymorphisms in XRCC1 gene are listed in Ensembl database. The most extensively studied are three genetic changes Arg194Trp, Arg280His, Arg399Gln [152]. The XRCC1 Arg399Gln genotype was linked with increased risk of tobacco-related cancers among light smokers, but decreased risk among heavy smokers. There are also controversial data on association of XRCC1 Arg280His and Arg399Gln polymorphisms with increased level of benzo[a]pyrene and other DNA adducts as well as increased frequency of chromosomal aberrations [19, 152], a biomarker of cancer risk. 
Extensive search for SNPs revealed that cancer risk may be increased in individuals bearing not one, but multiple polymorphisms in DNA repair genes, which if present separately have no effect on the frequency of cancer development. For example simultaneous presence of APE1 Asp148Glu and XRCC1 Arg194Trp polymorphisms increase the risk of pancreatic cancer, while each of these variants separately has no effect [153].

	Transcriptional regulation of BER

Transcription of BER genes is regulated in the cell cycle and may be also affected by increased oxidative stress [154]. The mRNA level of alkylpurine-DNA-N-glycosylase (ANPG), human thymine glycol-DNA-glycosylase (NTH), uracil-DNA-glycosylase (UDG), and human AP-endonuclease (APE) increase 2.5 – 3.5-fold during the G1 phase of the cell cycle, remain constant during the S phase, and decrease to the basal level, after mitosis. In contrast, expression of hOGG1 gene is not regulated during the cell cycle [155].
	BER genes may be also activated by the hydrogen peroxide and other ROS. Oxidative stress increases 2-3-fold hMTH1 mRNA expression and enzyme activity in cultured human fibroblasts [111], as well as hOGG1 mRNA and 8-oxoGua excising activity [112]. Transcription of the major human AP-endonuclease, APE1 is also augmented in response to ROS [156]. Since APE1 stimulates in vitro excision activity of OGG1 and TDG glycosylases several-fold [79, 80] stimulation of APE1 transcription will also stimulate 8-oxoGua and C excision rate. Thus, inflammations and infections exert a stimulatory effect on DNA repair by stimulating transcription of the BER system genes [157].
Cancer patients are usually characterized by increased oxidative stress, and one of the reasons is the depletion of antioxidant vitamins in these individuals [158]. Wilson and coworkers [159] showed that repair of 8-oxoGua was induced 5-6-fold by simultaneous treatment of cells with ascorbate and -tocopherol. This increase was accompanied by the increase of the level of DNA polymerase  and this could result from induced de novo synthesis of the enzyme. Dietary vitamins intake and/or individual vitamin absorption limitations may then influence people’s oxidative DNA damage repair capacity. Additional studies are necessary to elucidate importance of antioxidant vitamins intake/absorption for repair of oxidative DNA damage in the whole organism. 

Post-translational modifications of BER proteins

Several model studies demonstrate that repair activity of BER enzymes may be modulated by post-translational modifications, both non-enzymatic and enzymatic. The major enzymatic modifications include phosphorylation, acetylation and sumoylation.
OGG1 is phosphorylated by protein kinase C, Cdk4 and c-Abl kinases in several positions. Ser 326 phosphorylation triggers relocalisation of OGG1 from cytoplasm to nucleoli during S-phase, but does not affect enzyme’s excision activity [138]. Phosphorylation by Cdk kinase increases 8-oxoGua excision rate over 2-fold [123]. Phosphorylation of hMYH increases excision rate of A from 8-oxoGua:A pair. Defective phosphorylation of wild type hMYH was observed in colon cancer cell lines [160]. Phosphorylation of UNG2 glycosylase in Thr6 and Thr126 occurs 2 hrs after UV irradiation of mammalian cells and increases enzyme activity to remove from DNA uracil formed by UV-induced cytosine demination. Dephosphorylation is catalysed 8-10 hrs after UV treatment by TP53-induced protein phosphatase magnesium dependent 1D [161].
Acetylation by p300 protein is a common mechanism regulating activity of several BER proteins, namely OGG1, TDG, NEIL2, pol and APE1. OGG1 acetylation (Lys41 and Lys338) decreases OGG1 affinity for AP-sites and increases enzyme turnover, as well as increases its stimulation by APE1 [162]. In HeLa cells about 20% of OGG1 molecules are acetylated. The level of OGG1 acetylation is doubled upon oxidative stress. Acetylation of TDG occurs in enzyme region responsible for interaction with APE1 and abolishes its stimulation by APE1, but not DNA binding [163]. TDG acetylation releases it from the complex CBP/p300 and may play a role of molecular switch between two functions of TDG protein, DNA repair and a role of transcription factor [163]. Acetylation of NEIL2 at Lys49 significantly decreases glycosylase and AP-lyase activity of the enzyme [164]. Acetylation of pol at Lys47 decreases its dRP-lyase activity, but not DNA polymerase activity [165]. It is speculated that pol acetylation may play a role in BER directing towards SP- or LP-BER.
Sumoylation is an important mechanism changing conformation and activity of TDG glycosylase. Unsumoylated TDG has high affinity to DNA containing G:T and G:U mismatches as well as C and excises T, U and C from DNA. The enzyme has also high affinity to AP-sites and does not leave the reaction product. Binding of SUMO1 and SUMO2/3 proteins at Lys 330 in C-terminal domain of the TDG glycosylase changes enzyme conformation in N-terminal part. Change of conformation decreases enzyme affinity to DNA and facilitates its stimulation by APE1 [166].
The major known non-enzymatic modification of repair proteins is nitrosylation. Exogenous nitric oxide and peroxynitrite were shown to inhibit OGG1 [167], DNA ligase [168] formamidopyrimidine-DNA-glycosylase [169] and O6-alkylguanine-DNA-alkyltransferase by direct nitrosylation [170]. Inflammatory processes may then, on one hand stimulate transcription, and on the other, directly inactivate some repair enzymes.
Although currently nothing is known whether abovementioned modifications play a role in carcinogenesis induction or progression, such mechanisms can not be excluded since it was revealed that the level of MutY protein phospohorylation may affect its activity within the cell. MutY is adenine glycosylase that removes adenines from A:8-oxoGua mispairs. Experiments using colon cancer cell lines which did not exhibit mutations in MutY gene, showed that defective repair of A:8-oxoGua may be at least in part consequence of alterations in endogenous phosphorylation of the MutY protein [160].
Influence of post-translational modifications of BER enzymes on repair efficiencies in the whole organism awaits further research.

DNA REPAIR IN CANCER TISSUES

Cancer cells are characterized by increased oxidative insult and tremendous genomic instability, which results in changed metabolism, cell cycle frequency and loss of heterozygosity (LOH). We were investigating the DNA damage level and the rate of A, C and 8-oxoGua repair in lung tumours and non-affected lung tissues from lung cancer patients. No difference in A and C level between tumor and non-affected lung was recorded, however significant increase in excision rate of these two modified bases was observed in the tumor tissue, suggesting that oxidative stress is increased in cancer cells and that repair mechanisms may compensate it. Similarly, in colon benign adenomatous polyps the level of A and C was augmented, reflecting increased oxidative stress in the disease development. However, disease progression to carcinoma is accompanied by a drastic decrease of ethenoadducts level in DNA of tumors, even below that in non-affected colon [171]. Tumors have a higher content of cells in the S-phase. Expression of some DNA-glycosylases and AP-endonuclease genes was shown to be cell cycle dependent [155]. The mRNA levels of alkylpurine-DNA-N-glycosylase (ANPG), human thymine glycol-DNA-glycosylase (NTH), uracil-DNA-glycosylase (UDG), and human AP-endonuclease (APE) increase 2.5 – 3.5-fold during the G1 phase of the cell cycle, remain constant during the S phase, and decrease to the basal level, after mitosis. However, expression levels of gene for OGG1 is not regulated during the cell cycle [155]. It is then possible that increase of εC repair capacity in tumor was due to an increase in AP-endonuclease expression during the S phase of the cell cycle [155]. The enzyme transcript levels have been found to be elevated in a number of cancers [154, 172-174]. 
Surprisingly we observed decreased 8-oxoGua excision activity in tumor lung tissue in comparison with non-affected surrounding areas. The mechanism of this decrease is not known, but probably is not related to mutations in OGG1 gene in tumor, since they have been found in only 4% of human kidney cancers, and were also sporadic in lung cancers [175]. Some studies have shown frequent allelic loss in cancer tissue of chromosome fragments in the position locating OGG1 gene. Accordingly, the decrease of OGG1 expression was observed, e.g. in head and neck squamous cancer cases [176]. However, loss of heterozygosity in OGG1 locus may vary between cancers types. No differences in OGG1 expression were observed between tumor and non-affected surroundings in human lung and kidney cancers [175]. In model systems OGG1 activity is stimulated by at least two proteins, APE and XRCC1 [79, 177]. One cannot exclude deregulation in tumor tissue of OGG1 cooperation with downstream partners of the BER pathway, although APE expression was shown to increase in tumors. 
The decrease of OGG1 activity may also be tumor-specific, driven by the loss of OGG1 activators in tumor tissue. One such gene may be a tumor suppressor protein – tuberin.  In tuberin deficient Ekert rats, which spontaneously develop renal cancers, OGG1 expression and activity was reduced 3-fold [178]. Tumor-specific regulation of 8-oxoGua excision activity may also be due to mutations in tumor suppressor gene TP53. It was recently shown that TP53 plays a central role in the cellular response to genotoxic stress and is associated with the DNA repair machinery which involves base excision repair (BER). Using TP53 temperature-sensitive (ts) mutants of murine and human origin, it was observed that cell extracts overexpressing TP53 exhibited an augmented BER activity measured in an in vitro assay. Depletion of TP53 from the nuclear extracts abolished this enhanced activity [179]. TP53 may also interact directly with the BER complex. For example it was found that recombinant TP53 protein stimulated an in vitro reconstituted BER assay, potentially by binding APE-1 and regulating DNA polymerase β (pol β) loading onto AP-sites [180]. On the other hand TP53 may also regulate genes involved in BER [181]. Treated with the base damaging alkylating agent MMS TP53 null cells exhibited slow BER, as measured in vivo using an alkaline comet assay. In this experimental system, pol β protein levels correlated with wild type TP3 status, though APE1 levels and activity were unaffected. In fact, previous studies have identified polβ as a DNA damage inducible gene [182], thus raising the possibility that it is transcriptionally regulated by p53.
Another signaling protein that might regulate repair of oxidative DNA damage in cancer tissues is APC protein. APC tumor suppressor protein inhibits long patch BER (LP-BER, e.g. engaged in repair of A and C) via direct interaction with DNA polymerase  and FEN-1 endonuclease [183]. BER activity was inversely associated with APC expression in several breast cancer cell lines [184]. Since mutations in APC gene are early events in colorectal carcinogenesis, and they are found in about 37 % of colon tumors [185], this mechanism may be important in regulating repair of ethenoadducts in colon tumors. Over-stimulating and un-balancing of BER may in turn favor genomic instability and in consequence cancer progression. It was shown that in tissues from non-cancerous colons of ulcerative colitis patients, methylpurine-DNA glycosylase (ANPG) and abasic sites endonuclease (APE1) were significantly increased, and microsatellite instability (MSI) was positively correlated with their imbalanced repair enzymatic activities. These latter results were supported by mechanistic studies using yeast and human cell models in which overexpression of Mpg and/or Ape1 was associated with frameshift mutations and MSI [186]. 
Imbalanced expression of DNA repair enzymes may also affect cellular availability of signaling molecules. APE1 is a redox factor for several transcription factors including AP-1, HIF1-alpha, and p53 [187]. Thymine-DNA glycosylase (TDG) also stimulates transcription of TP53 family proteins, TP53 and TP73, and stimulates growth repression, mediated by these proteins [188]. So over expression of some BER enzymem, like APE1, on one hand will stimulate genome instability, and on the other will repress cell growth to enable DNA repair. 

	OXIDATIVE PROCESSES IN AGING

Lipid peroxidation as an endogenous source of degeneration and aging 

Lipid peroxidation is implicated in aging as well as in the pathogenesis of numerous human diseases, including atherosclerosis, cancer, diabetes and arthritis [189]. Significant increase in the LPO level was found in skeletal muscle of old individuals [190], as well as in hepatocytes isolated from old ovariectomized rats [191].  
Peroxidation of cellular membrane lipids, or circulating lipoprotein molecules generates highly reactive aldehydes among which one of most important is 4-hydroxynonenal (HNE, Fig. 4.). The presence of HNE is increased in brain tissue and cerebrospinal fluid of Alzheimer Disease patients, and in spinal cord of amyotrophic lateral sclerosis (ALS) patients. Increased levels of HNE in neurodegenerative disorders and immunohistochemical distribution of HNE in brain tissue indicate pathophysiological role of oxidative stress in these diseases, and especially HNE in formation of abnormal filament deposites [21] .
Physiological concentrations of HNE vary from 0.1-3 M, and can increase up to 50 M or even milimolar values under oxidative stress [192]. Within cells, HNE binds primarily to thiols and proteins, depleting glutathione levels and forming protein-protein cross-links, which may accelerate formation of deposits [193]. Glutathione depletion by HNE is probably an important mechanism of aging. Lifespan and stress resistance of Caenorhabditis elegans are increased by expression of glutathione transferases capable of metabolizing HNE [194] .
HNE also forms bulky adducts to DNA bases. These are exocylic propano- and etheno-type adducts, which bear six or seven carbon atom side chains [195]. These adducts are relatively unstable, and may rearrange, forming DNA intra- and interstrand cross-links [196], as well as DNA-protein cross-links [197]. HNE-dG adducts were detected in DNA of non-exposed humans and rodents, which indicates their endogenous source [198, 199] 


Figure 4. Examples of HNE and its epoxide adducts to deoxyguanosine.

We have shown that HNE-DNA adducts block replication, trigger recombination, base substitutions and frameshift mutations in model system, ssM13 phage [200]. Other studies showed that in mammalian cells HNE increases the frequency of micronuclei, chromosomal aberrations, sister-chromatid exchanges [201-203] and point mutations [204], already at low, physiological concentrations of 0.1-10 µM. HNE also exerts a clastogenic effect in human cells, possibly via inactivation of the functional SH groups in DNA polymerases [205]. 
Several degenerative diseases are related to malfunctioning of DNA repair. One of such diseases is Cockayne syndrome (CS). Cockayne syndrome is characterized by traits reminiscent of normal aging, such as neurological degeneration, cataracts and systemic growth failure. The majority of CS cases are caused by defects in the CS complementation group B (CSB) protein. The CSB gene encodes a 168 kDa protein belonging to the SWI2/SNF2 protein family. The CSB protein participates in both sub-pathways of nucleotide excision repair (NER), mainly in transcription-coupled repair (TCR), but also in global genome repair (GGR). CSB is also engaged in base excision repair (BER) of certain types of oxidative DNA damage, e.g. 8-oxoGua [206], in the poly(ADP-ribose) polymerase-1 (PARP-1) mediated response to oxidative DNA damage [207], in strand annealing and exchange, which might be engaged in mitotic recombination [208], as well as in general transcription. 
We have found [209] that human CSB-deficient cells are hypersensitive to physiological concentrations (1-10 M) of HNE, and in response to HNE they develop a higher level of sister chromatid exchanges in comparison to the wild type cells. We have also demonstrated that HNE-DNA adducts block in vitro transcription by T7 RNA polymerase, as well as by HeLa cell-free extracts. Transcription inhibition leads to stabilization of TP53 protein and, thus, triggers apoptosis [210]. This might, at least partially explain accelerated aging and degeneration in CS patients. Treatment of wild type cells with low HNE concentrations, 1-20 M, caused dephosphorylation of the CSB protein, which stimulates its ATPase activity necessary for TCR. However, high HNE concentrations (100-200 M) inhibit in vitro CSB ATPase activity as well as the transcription machinery in HeLa cell-free extracts. These results suggest that HNE-DNA adducts are extremely toxic endogenous DNA lesion, and that their processing involves CSB. When these lesions are not removed from the transcribed DNA strand due to CSB gene mutation or CSB protein inactivation by high, pathological HNE concentrations, they may contribute to accelerated aging. 
Inhibition of removal of UV dimmers and benzo[a]pyrene adducts from DNA (performed mainly by NER pathway) by the products of lipid peroxidation, HNE, malondialdehyde and acrolein was already reported [211-213] 
What is the contribution of such mechanism in aging process on the level of the whole organism still is not clear.  

Age-related changes in oxidative DNA damage in humans (see also Olinski R. et al. [214])

A number of research groups have reported on the effect of aging on DNA oxidation in animal model [215, 216]. However, a summary of these kinds of studies shows no clear effect. It is difficult to explain why in some studies age-related increase in oxidative DNA damage was observed [217], whereas in others no effect was described [218]. It is possible that one reason for the discrepancies may be the reliability of the biomarkers used. Moreover, to date no comprehensive studies concerning age-related oxidative DNA damage in humans have been conducted. 
Therefore, the purpose of our recently published work [219] was to assess age-related changes in oxidative DNA damage in humans. For the first time, the broad spectrum of oxidative DNA damage biomarkers was analysed; urinary excretion of 8-oxodG and 8‑oxoGua as well as the level of oxidative DNA damage in leukocytes. All parameters were determined in 255 healthy subjects divided into four age-related groups: group A - children (mean age 13), group B - adults (mean age 31), group C - middle age (mean age 50), and group D - elderly (mean age 67).
Antioxidant vitamins (A, C and E) and uric acid are effective free radical scavengers therefore they should protect biomolecules such as DNA. In addition to the aforementioned analyses a concentration of antioxidant vitamins A, C, E and uric acid was determined in blood serum. 
There was a highly significant rise in the background level of 8-oxodG in leukocytes’ DNA in elderly and middle age groups in comparison with adults (Fig. 5), and a statistically significant, positive correlation between age and 8-oxodG levels in leukocytes’ DNA. 


Figure 5. The mean level of 8-oxodG in leukocytes’ DNA in different age groups. 


Figure 6. Correlation between the level of 8-oxodG in leukocytes’ DNA and age with exclusion of the group A.

However, a steady increase of 8-oxodG levels in DNA isolated from leukocytes together with age was seen only when the youngest group was excluded (Fig. 6), since the level was significantly elevated in the group of youngest subjects (group A) when compared with the group representing “adults” (group B). It is likely that the unexpected high level of oxidative DNA damage in group A may reflect the higher metabolic rate of children. Children who are growing fast have a higher metabolic rate than adults. High metabolic rate, in turn, requires a high level of mitochondria respiration and subsequent elevated production of ROS, which are responsible for the formation of DNA modifications analyzed in our work. Indeed in our previous study highly significant, positive correlations between specific metabolic rates and urinary excretion rates for 8-oxodG and 8-oxoGua were found [220].
The obvious question is why does oxidative DNA damage increase with age? The background level of 8-oxoGua in cellular DNA represents a dynamic equilibrium between the rate of oxidative DNA damage formation, and the rate of repair of the damage. Therefore, the observed age-related increase may be a result of deficiency in the ability of the cells from older subjects to remove the damage or it may mirror an intensification of processes responsible for the damage formation or both. 
An age-related decrease in DNA repair capacity has been demonstrated mostly for nucleotide excision repair (NER) [221, 222]. However, base excision repair (BER) is primarily responsible for the removal of oxidatively-generated DNA base damage, and age-dependent reduction of hOGG1, the major enzyme involved in the removal of 8-oxoguanine, was also reported [223].
Urinary excretion rate, especially that measuring the level of 8-oxoGua is the most sensitive marker of the average oxidative stress to DNA of all body cells [224, 225]. Therefore besides analyses of the background level of 8-oxodG in leukocytes’ DNA also urinary excretion of the modified base and nucleosides was determined. Since both parameters showed a similar age-related pattern it is likely that their changes reflect, at least in part, age-dependent intensification of oxidative stress which resulted in DNA damage. However, since urinary excretion rates may also represent repair processes (see [226]), we cannot entirely exclude the possibility that the observed less distinct changes in age-dependent urinary excretion rates than of the background level of 8-oxodG in DNA (compare Fig.5 and 7A, 7B) may also reflect some deterioration of the repair mechanism(s). Hence, age-related increase of oxidative stress appears to elevate oxidative DNA damage and the rate of repair represented by 8-oxoGua excretion although the activation of the repair process does not prevent accumulation of 8-oxodG in cellular DNA.

Figure7. The mean levels of 8-oxoGua (A) and 8-oxodG (B) in urine in the different age groups.
Impaired mitochondrial function is a factor which may be responsible for increased ROS production and therefore predispose to oxidative stress and DNA damage in the aged subjects. Indeed, several studies of the mitochondrial respiratory chain function in humans and animals have demonstrated an age-related decrease in respiration and increased production of ROS during aging [227, 228]. Another support for the age-related decline in mitochondrial function is provided by the demonstration that the amount of COX deficient muscle fiber increase in healthy aging humans [229].
Another source of age-related increase of oxidative stress may be decline of antioxidant defense and age-dependent decline in the concentration of vitamin C in plasma was also observed (Fig. 8). Vitamin C is a major aqueous-phase antioxidant. It should also be remembered that vitamin C acts in synergy with tocopherol by regenerating tocopheroxyl radical to tocopherol. One of the plausible explanations of the above-presented changes in vitamin concentrations is the sequential consumption of these antioxidants as a result of age-dependent intensification of oxidative stress. It was shown that during free radical mediated oxidation a decrease in vitamin E concentration  in plasma can only be seen after the complete consumption of vitamin C. The sequential consumption of these antioxidants was also shown by the use of ESR spectroscopy [230]. 

Figure 8. Relationship between the level of vitamin C and age in all studied subjects. 
As can be seen in Figure 5 the “adult” group exhibits the lowest values of oxidative DNA damage in leukocytes. Evolution theory assumes that organisms are not programmed to age, instead evolution selects for survival and reproduction [231]. Therefore, it is possible that the lowest values of this harmful, potentially mutagenic, oxidatively-modified DNA in the aforementioned group may constitute a proof of “specific concern” of evolution for humans of reproductive age. Individuals differ greatly in their rate of aging. There are also quite substantial inter-individual differences in the level of 8-oxodG in DNA (Fig 5 and 6). These differences can be also seen within the “adult” group with a subgroup where the values are around 2 modifications per 106 unmodified bases and the second subpopulation where the values are much higher than the mean level (Fig. 5 and 6). It has been postulated that different factors which may influence genome in adult life may influence the rate of subsequent functional decline of the organism [232]. Therefore, it is possible that one of these factors is oxidative DNA damage with genome destabilizing properties.

Why different mammalian species age at different rates?

One of the intriguing issues concerning aging process comprise a question - why different mammalian species age at different rates. One hypothesis that has attempted to explain these differences is once again the free radical theory of aging [233, 234]. All aerobic organisms utilize oxygen which is linked to the production of reactive oxygen species (ROS). The above-mentioned differences may be explained, at least partially, by different metabolic rate that in turn is connected with oxygen consumption and ATP production during oxidative phosphorylation. The more ATP that is required, the more oxygen that must pass through the mitochondria and the more oxygen radicals that are likely to be generated. The more oxygen radicals the greater will be the damage to cellular components including DNA. Oxidative DNA damage is removed via different repair pathways. Following excision from DNA, the oxidatively induced lesions are released into the blood stream and consequently into the urine, where their measurement has been acknowledged to be reflective of overall oxidative stress [235]. 
In our study we decided to analyze urinary excretion of possible repair products of oxidative DNA damage: 8-oxoGua, 8-oxodG and 5-(hydroxymethyl)uracil (5-HMUra), in mammalian species that substantially differ in metabolic rate and longevity, namely mice, rats, rabbits, dogs, pigs and humans [236]. 
The analyzed excretion rates should depend on oxygen consumption and metabolic rate. In turn, the metabolic rate may be described by specific metabolic rate (SMR) values [237, 238]. In agreement with these assumptions we have found good positive correlations between SMRs of different species and their excretion rates of all analyzed modifications (Fig. 9). 




Figure 9. Relationship between the urinary excretion rates of the analyzed modifications and specific metabolic rates (SMR) of six different mammalian species. 


Figure 10. Relationship between the urinary excretion rates of the analyzed modifications and natural logarithm from maximum life span (MLSP) of six different mammalian species. 
The correlation of the excretion rate of 8-oxoGua with MLSP, found in our work, is in good agreement with previous studies, which demonstrated that oxidative damage to DNA is inversely related to MLSP of different mammals. However, in the aforementioned studies no humans were included and the assessment of DNA damage was restricted to certain organs [242-244]. In contrast, the analyses of the urinary base/nucleoside products presented in this work are reflective of oxidative DNA damage on the level of the whole organism. Our results demonstrated that ROS continually damage DNA and that this damage in vivo, in normal conditions is lower in long-lived species than in short-lived species. Incomplete repair of such damage would lead to its accumulation over time and eventually result in age-related deterioration.
Expression of the urinary excretion rates in nmol/kg/24h enables measurement of the number of the repaired lesions per day per cell [245]. Interestingly, urinary level of all measured modifications, found in our study accounted for about 28,200 repaired events per average cell of the mouse per day and fits well with the estimation of Hamilton and co-workers who calculated that the DNA of the liver cell in mouse is exposed to about 47,000 8‑oxoGua lesions in a 24 hour period [246] (taking into consideration that the liver is a high metabolic rate organ and that our values are an average for the whole organism). In contrast, the number of all lesions analyzed in our work, in humans accounts for about 2,800 repair events in the average cell per day. It is therefore possible that high metabolic rate in mouse (or other short lived animal) may be responsible for severe everyday oxidative DNA insult that may be accumulated faster than in long-lived species. It is also noteworthy that the difference in urinary excretion of 8-oxoGua between mice and humans is very similar to the difference in reported oxygen consumption between these species /10 fold and 11 fold respectively [247].




It is becoming increasingly apparent that oxidative damage plays a role in numerous pathological conditions [49]. However, greater knowledge of whether oxidative DNA damage initiates the disease process or is merely a by-product of the disease development is of critical importance. On the basis of the presented data and literature reports it seems reasonable to postulate that oxidative DNA damage/oxidative stress is probably a contributing factor in the aging. However, mechanisms that underline aging are highly complex and may depend on different factors like genetic background, dietary behavior, life style,  to name a few. Thus, oxidative stress may contribute in a limiting extend in the aging of some individuals and could be a major factor in others. It should be also remembered that association between oxidative stress and aging is complicated by the considerations that there is no general agreement as to what aging is, when aging begins and what triggers its onset and that oxidative stress occurs by multiple mechanisms. 
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